Abbott (NYSE:ABT) announced today that its Xience stent received CE mark approval for a shorter duration of dual anti-platelet therapy (DAPT).
The European approval for the stent allows for the DAPT to go as short as 28 days, the shortest indication available in the world for patients with high bleeding risk (HBR), according to a news release.
Get the full story at our sister site, Medical Tubing & Extrusion.
Top: Teleflex Langston Dual Lumen catheter; Bottom: BSX Imager II, Endologix Ovation iX, Teleflex AC3 Optimus Intra-Aortic balloon pump
The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA.
FDA in 2020 reported a total 33 medical device recalls at its most serious Class I level, down from 49 in 2019.
The list of the most serious catheter-based device recalls in 2020 includes products from major companies including Medtronic and Teleflex, and catheters ranging from congenital heart treatment devices to contrast material delivery devices.
Here are the nine most serious catheter-based device recalls of 2020.
Next >>The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA.
FDA in 2020 reported a total 33 medical device recalls at its most serious Class I level, down from 49 in 2019.
The list of the most serious catheter-based device recalls in 2020 includes products from major companies including Medtronic and Teleflex, and catheters ranging from congenital heart treatment devices to contrast material delivery devices.
Here are the nine most serious catheter-based device recalls of 2020.
Next >>